Szabolcs David

Szabolcs David

Auto-generated profile, based on publicly available information

Szabolcs David

Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
LMLena Maier-Hein
Lena Maier-Hein
PNPeter F. Neher
Peter F. Neher
JHJean-Christophe Houde
Jean-Christophe Houde
MCMarc-Alexandre Côté
Marc-Alexandre Côté
EGEleftherios Garyfallidis
Eleftherios Garyfallidis
Maxime DescoteauxMaxime Descoteaux
Maxime Descoteaux
Tractography based on non-invasive diffusion imaging is central to the study of human brain connectivity. To date, the approach has not been systematically validated in ground truth studies. Based on a simulated human brain data set with ground truth tracts, we organized an open international tractography challenge, which resulted in 96 distinct submissions from 20 research groups. Here, we report the encouraging finding that most state-of-the-art algorithms produce tractograms containing 90% of the ground truth bundles (to at least some extent). However, the same tractograms contain many more invalid than valid bundles, and half of these invalid bundles occur systematically across research groups. Taken together, our results demonstrate and confirm fundamental ambiguities inherent in tract reconstruction based on orientation information alone, which need to be considered when interpreting tractography and connectivity results. Our approach provides a novel framework for estimating reliability of tractography and encourages innovation to address its current limitations.

1 January 2021 in Clinical and Translational Radiation Oncology
Verified
Journal Article
Open access
SNSteven H.J. Nagtegaal
Steven H.J. Nagtegaal
SDSzabolcs David
Szabolcs David
MPMarielle Philippens
Marielle Philippens
TSTom J. Snijders
Tom J. Snijders
ALAlexander Leemans
Alexander Leemans
JVJoost J.C. Verhoeff
Joost J.C. Verhoeff
The relation between radiotherapy (RT) dose to the brain and morphological changes in healthy tissue has seen recent increased interest. There already is evidence for changes in the cerebral cortex and white matter, as well as selected subcortical grey matter (GM) structures. We studied this relation in all deep GM structures, to help understand the aetiology of post-RT neurocognitive symptoms. We selected 31 patients treated with RT for grade II-IV glioma. Pre-RT and 1 year post-RT 3D T1-weighted MRIs were automatically segmented, and the changes in volume of the following structures were assessed: amygdala, nucleus accumbens, caudate nucleus, hippocampus, globus pallidus, putamen, and thalamus. The volumetric changes were related to the mean RT dose received by each structure. Hippocampal volumes were entered into a population-based nomogram to estimate hippocampal age. A significant relation between RT dose and volume loss was seen in all examined structures, except the caudate nucleus. The volume loss rates ranged from 0.16 to 1.37%/Gy, corresponding to 4.9–41.2% per 30 Gy. Hippocampal age, as derived from the nomogram, was seen to increase by a median of 11 years. Almost all subcortical GM structures are susceptible to radiation-induced volume loss, with higher volume loss being observed with increasing dose. Volume loss of these structures is associated with neurological deterioration, including cognitive decline, in neurodegenerative diseases. To support a causal relationship between radiation-induced deep GM loss and neurocognitive functioning in glioma patients, future studies are needed that directly correlate volumetrics to clinical outcomes.

5 March 2019 in Frontiers in Neuroanatomy
Verified
Journal Article
Open access
PDF file
SDSzabolcs David
Szabolcs David
AHAnneriet M Heemskerk
Anneriet M Heemskerk
FCFrancesco Corrivetti
Francesco Corrivetti
MSMichel Thiebaut de Schotten
Michel Thiebaut de Schotten
SSSilvio Sarubbo
Silvio Sarubbo
ALAlexander Leemans
Alexander Leemans
Fiber tractography (FT) using diffusion magnetic resonance imaging (dMRI) is widely used for investigating microstructural properties of white matter (WM) fiber-bundles and for mapping structural connections of the human brain. While studying the architectural configuration of the brain’s circuitry with FT is not without controversy, recent progress in acquisition, processing, modeling, analysis, and visualization of dMRI data pushes forward the reliability in reconstructing WM pathways. Despite being aware of the well-known pitfalls in analyzing dMRI data and several other limitations of FT discussed in recent literature, we present the superoanterior fasciculus (SAF), a novel bilateral fiber tract in the frontal region of the human brain that—to the best of our knowledge—has not been documented. The SAF has a similar shape to the anterior part of the cingulum bundle, but it is located more frontally. To minimize the possibility that these FT findings are based on acquisition or processing artifacts, different dMRI data sets and processing pipelines have been used to describe the SAF. Furthermore, we evaluated the configuration of the SAF with complementary methods, such as polarized light imaging (PLI) and human brain dissections. The FT results of the SAF demonstrate a long pathway, consistent across individuals, while the human dissections indicate fiber pathways connecting the postero-dorsal with the antero-dorsal cortices of the frontal lobe.

1 March 2017 in Neuroscience
Verified
Journal Article
Closed access
TSTamás Spisák
Tamás Spisák
ZPZsófia Pozsgay
Zsófia Pozsgay
CACsaba Aranyi
Csaba Aranyi
SDSzabolcs Dávid
Szabolcs Dávid
PKPál Kocsis
Pál Kocsis
ZKZsigmond Tamás Kincses
Zsigmond Tamás Kincses

1 June 2019 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
SNSteven H.J. Nagtegaal
Steven H.J. Nagtegaal
SDSzabolcs David
Szabolcs David
ABArthur T.J. van der Boog
Arthur T.J. van der Boog
ALAlexander Leemans
Alexander Leemans
JVJoost J.C. Verhoeff
Joost J.C. Verhoeff

15 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMiklós Sárvári
Miklós Sárvári
PKPál Kocsis
Pál Kocsis
LDLevente Deli
Levente Deli
DGDávid Gajári
Dávid Gajári
SDSzabolcs Dávid
Szabolcs Dávid
ZLZsolt Liposits
Zsolt Liposits
The orexigenic gut-brain peptide, ghrelin and its G-protein coupled receptor, the growth hormone secretagogue receptor 1a (GHS-R1A) are pivotal regulators of hypothalamic feeding centers and reward processing neuronal circuits of the brain. These systems operate in a cooperative manner and receive a wide array of neuronal hormone/transmitter messages and metabolic signals. Functional magnetic resonance imaging was employed in the current study to map BOLD responses to ghrelin in different brain regions with special reference on homeostatic and hedonic regulatory centers of energy balance. Experimental groups involved male, ovariectomized female and ovariectomized estradiol-replaced rats. Putative modulation of ghrelin signaling by endocannabinoids was also studied. Ghrelin-evoked effects were calculated as mean of the BOLD responses 30 minutes after administration. In the male rat, ghrelin evoked a slowly decreasing BOLD response in all studied regions of interest (ROI) within the limbic system. This effect was antagonized by pretreatment with GHS-R1A antagonist JMV2959. The comparison of ghrelin effects in the presence or absence of JMV2959 in individual ROIs revealed significant changes in the prefrontal cortex, nucleus accumbens of the telencephalon, and also within hypothalamic centers like the lateral hypothalamus, ventromedial nucleus, paraventricular nucleus and suprachiasmatic nucleus. In the female rat, the ghrelin effects were almost identical to those observed in males. Ovariectomy and chronic estradiol replacement had no effect on the BOLD response. Inhibition of the endocannabinoid signaling by rimonabant significantly attenuated the response of the nucleus accumbens and septum. In summary, ghrelin can modulate hypothalamic and mesolimbic structures controlling energy balance in both sexes. The endocannabinoid signaling system contributes to the manifestation of ghrelin's BOLD effect in a region specific manner. In females, the estradiol milieu does not influence the BOLD response to ghrelin.